Recruiting
Study on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage
Registered drugNo placebo
Study on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage
Registered drugNo placebo
- Disease:Reversible cerebral vasoconstriction syndrome
- Substances:Amlodipine
Countries:
Finland
Finland- Participants:18–64 years · 65+ years
- Substances:Amlodipine
- Sponsor:HUS Helsinki University Hospital
